Seth Karp, M.D., professor of Surgery and Ingram Professor of Surgical Sciences, has been named the new chair of Vanderbilt’s Department of Surgery.
A specific gene expression profile represents a novel, biologically relevant “signature” for identifying colon cancers with high risk of metastatic recurrence, Vanderbilt researchers have found.
Eighteen academic and administrative leaders at Vanderbilt University have been elected fellows of the American Association for the Advancement of Science (AAAS) this year.
A newly identified factor regulates blood vessel growth in colorectal tumors and could be a promising target for cancer therapies.
R. Daniel Beauchamp, M.D., chair of the Section of Surgical Sciences, and Sten Vermund, M.D., Ph.D., director of the Vanderbilt Institute for Global Health, have been elected to the Institute of Medicine (IOM), the organization announced this week.
New information about signaling pathways involved in colorectal cancer could aid in assessing prognosis and identifying new therapeutic targets for the disease.